학술논문
O-1 Liposomal irinotecan + 5-fluorouracil/leucovorin + oxaliplatin (NALIRIFOX) versus nab-paclitaxel + gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma: Sensitivity analysis of survival from the NAPOLI 3 trial
Document Type
Abstract
Author
Source
In Annals of Oncology June 2023 34 Supplement 1:S180-S180
Subject
Language
ISSN
0923-7534